vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $75.1M, roughly 1.0× SAUL CENTERS, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 10.6%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 6.2%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
BFS vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $75.5M |
| Net Profit | $6.5M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 65.4% | 22.7% |
| Net Margin | 8.7% | — |
| Revenue YoY | 10.6% | 27.7% |
| Net Profit YoY | -19.6% | — |
| EPS (diluted) | $0.15 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $75.5M | ||
| Q3 25 | $72.0M | $54.5M | ||
| Q2 25 | $70.8M | $52.4M | ||
| Q1 25 | $71.9M | $46.0M | ||
| Q4 24 | $67.9M | $59.1M | ||
| Q3 24 | $67.3M | $80.5M | ||
| Q2 24 | $66.9M | $47.1M | ||
| Q1 24 | $66.7M | $43.8M |
| Q4 25 | $6.5M | — | ||
| Q3 25 | $10.5M | $8.8M | ||
| Q2 25 | $10.7M | $5.9M | ||
| Q1 25 | $9.8M | $3.0M | ||
| Q4 24 | $8.1M | — | ||
| Q3 24 | $14.5M | $20.3M | ||
| Q2 24 | $14.4M | $-4.5M | ||
| Q1 24 | $13.6M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | 73.6% | 63.9% | ||
| Q2 24 | 74.2% | 77.4% | ||
| Q1 24 | 72.8% | 75.5% |
| Q4 25 | 65.4% | 22.7% | ||
| Q3 25 | 69.1% | 17.6% | ||
| Q2 25 | 68.7% | 12.7% | ||
| Q1 25 | 66.5% | 8.7% | ||
| Q4 24 | 82.9% | 22.6% | ||
| Q3 24 | 72.8% | 27.4% | ||
| Q2 24 | 75.0% | -4.6% | ||
| Q1 24 | 72.4% | -5.3% |
| Q4 25 | 8.7% | — | ||
| Q3 25 | 14.6% | 16.2% | ||
| Q2 25 | 15.1% | 11.2% | ||
| Q1 25 | 13.6% | 6.5% | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 21.5% | 25.2% | ||
| Q2 24 | 21.6% | -9.6% | ||
| Q1 24 | 20.4% | -11.0% |
| Q4 25 | $0.15 | $0.26 | ||
| Q3 25 | $0.32 | $0.17 | ||
| Q2 25 | $0.33 | $0.12 | ||
| Q1 25 | $0.29 | $0.06 | ||
| Q4 24 | $0.22 | $0.40 | ||
| Q3 24 | $0.48 | $0.41 | ||
| Q2 24 | $0.48 | $-0.09 | ||
| Q1 24 | $0.45 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $97.5M |
| Total DebtLower is stronger | $468.4M | $22.7M |
| Stockholders' EquityBook value | $307.8M | $130.3M |
| Total Assets | $2.2B | $216.3M |
| Debt / EquityLower = less leverage | 1.52× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.7M | $97.5M | ||
| Q3 25 | $11.8M | $94.4M | ||
| Q2 25 | $5.3M | $96.0M | ||
| Q1 25 | $6.5M | $93.2M | ||
| Q4 24 | $10.3M | $101.0M | ||
| Q3 24 | $7.2M | $96.7M | ||
| Q2 24 | $6.9M | $96.8M | ||
| Q1 24 | $7.1M | $107.2M |
| Q4 25 | $468.4M | $22.7M | ||
| Q3 25 | $1.6B | $34.0M | ||
| Q2 25 | $1.6B | $45.3M | ||
| Q1 25 | $1.5B | $56.7M | ||
| Q4 24 | $455.8M | $68.0M | ||
| Q3 24 | $1.5B | $79.3M | ||
| Q2 24 | $1.4B | $90.7M | ||
| Q1 24 | $1.4B | $102.0M |
| Q4 25 | $307.8M | $130.3M | ||
| Q3 25 | $316.6M | $115.3M | ||
| Q2 25 | $322.4M | $104.7M | ||
| Q1 25 | $328.4M | $97.1M | ||
| Q4 24 | $335.8M | $92.1M | ||
| Q3 24 | $341.8M | $71.1M | ||
| Q2 24 | $345.7M | $48.5M | ||
| Q1 24 | $347.1M | $51.0M |
| Q4 25 | $2.2B | $216.3M | ||
| Q3 25 | $2.2B | $202.9M | ||
| Q2 25 | $2.1B | $194.9M | ||
| Q1 25 | $2.1B | $196.2M | ||
| Q4 24 | $2.1B | $213.3M | ||
| Q3 24 | $2.1B | $220.7M | ||
| Q2 24 | $2.1B | $205.0M | ||
| Q1 24 | $2.0B | $214.1M |
| Q4 25 | 1.52× | 0.17× | ||
| Q3 25 | 5.02× | 0.30× | ||
| Q2 25 | 4.85× | 0.43× | ||
| Q1 25 | 4.70× | 0.58× | ||
| Q4 24 | 1.36× | 0.74× | ||
| Q3 24 | 4.37× | 1.12× | ||
| Q2 24 | 4.17× | 1.87× | ||
| Q1 24 | 4.06× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 15.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.8M | $14.4M | ||
| Q3 25 | $20.6M | $9.7M | ||
| Q2 25 | $26.6M | $14.1M | ||
| Q1 25 | $30.4M | $3.6M | ||
| Q4 24 | $121.2M | $15.6M | ||
| Q3 24 | $26.5M | $11.0M | ||
| Q2 24 | $32.1M | $1.0M | ||
| Q1 24 | $33.8M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $-28.3M | $11.0M | ||
| Q2 24 | $-12.5M | $1.0M | ||
| Q1 24 | $-11.7M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | -42.1% | 13.7% | ||
| Q2 24 | -18.7% | 2.1% | ||
| Q1 24 | -17.6% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 81.5% | 0.0% | ||
| Q2 24 | 66.7% | 0.0% | ||
| Q1 24 | 68.3% | 0.0% |
| Q4 25 | 15.35× | — | ||
| Q3 25 | 1.97× | 1.10× | ||
| Q2 25 | 2.48× | 2.41× | ||
| Q1 25 | 3.10× | 1.21× | ||
| Q4 24 | 14.98× | — | ||
| Q3 24 | 1.83× | 0.54× | ||
| Q2 24 | 2.22× | — | ||
| Q1 24 | 2.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
